STOCK TITAN

Elutia grants Michelle LeRoux Williams 446,000 options

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
4

Rhea-AI Filing Summary

Elutia Inc. Chief Scientific Officer Michelle LeRoux Williams received a grant of stock options covering 446,000 shares of Class A Common Stock on November 10, 2026. The options have an exercise price of $0.93 per share and vest monthly over four years from November 9, 2026; they become fully vested and exercisable on November 9, 2030, subject to her continued service through each vesting date. The options expire November 10, 2036.

Insider Williams Michelle LeRoux
Role CHIEF SCIENTIFIC OFFICER
Type Security Shares Price Value
Grant/Award Stock Option (Right to Buy) F1 446,000 $0.00 $0.00
Holdings After Transaction: Stock Option (Right to Buy) — 446,000 options (Direct)
Footnotes (1)
  1. F1. The option vests monthly over four years based on a vesting commencement date of November 9, 2026 such that the option shall be fully vested and exercisable on November 9, 2030, subject to the Reporting Person's continued service through each vesting date.
Stock options granted 446,000 options Granted November 10, 2026, covering Class A Common Stock
Exercise price $0.93 per share Price to exercise the options
Vesting period Four years Options vest monthly from November 9, 2026, subject to continued service through each vesting date
Fully vested and exercisable date November 9, 2030 As stated for the option award
Expiration date November 10, 2036 Option award expiration
vesting commencement date financial
"vesting commencement date of November 9, 2026"
The vesting commencement date is the starting point when an employee begins earning ownership rights to their promised benefits, such as stock options or retirement contributions. Think of it like the day a savings account is opened—only after this date do the benefits start to grow and become fully available over time. It matters to investors because it marks when the clock begins ticking toward full ownership, affecting the timing and value of these benefits.
fully vested and exercisable financial
"fully vested and exercisable on November 9, 2030"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many ELUT stock options did Michelle LeRoux Williams receive, and at what exercise price?

Chief Scientific Officer Michelle LeRoux Williams received options covering 446,000 shares of Class A Common Stock, with an exercise price of $0.93 per share.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Williams Michelle LeRoux

(Last)(First)(Middle)
C/O ELUTIA INC.
20 FIRSTFIELD ROAD

(Street)
GAITHERSBURG MARYLAND 20878

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
ELUTIA INC. [ ELUT ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
CHIEF SCIENTIFIC OFFICER
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
11/10/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Stock Option (Right to Buy)$0.9311/10/2026A446,000 (1)11/10/2036Class A Common Stock446,000$0446,000D
Explanation of Responses:
1. The option vests monthly over four years based on a vesting commencement date of November 9, 2026 such that the option shall be fully vested and exercisable on November 9, 2030, subject to the Reporting Person's continued service through each vesting date.
/s/ Jeffrey Hamet, Attorney-in-Fact for Michelle LeRoux Williams11/12/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Keep reading